Clark Atlanta University Awarded $7.4M NIH Cancer Research Grant
News May 14, 2014
The five-year grant, which was awarded by the National Institute on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health, supports cancer research infrastructure including technical research core laboratories and funding for the recruitment of researchers and for pilot studies.
“The Center for Cancer Research and Therapeutic Development is vitally important in establishing research collaborations with both academic and lay communities that are critical to the prevention, detection and treatment of prostate cancer and elimination of prostate cancer disparities,” said Dr. Shelia A. McClure, acting director, Office of Research Training and Capacity Building, Division of Scientific Programs, NIMHD, and a program official for the grant. “The center also serves as an important vehicle for training the next generation of investigators, particularly those from underrepresented groups.”
NIMHD supports research capacity-building in institutions that serve populations where the burden of disease is greatest.
The research and training efforts of CCRTD are focused on prostate cancer. Researchers are studying the biological, behavioral and social factors that contribute to the second most common cause of death from cancer among black, white, American Indian/Alaska Native, and Latino men. They are also studying the disproportionate impact of prostate cancer on black men, who have the highest risk of developing prostate cancer, the highest risk of developing aggressive prostate cancer, and also have the highest mortality rate. In concert with the research activities, CCRTD has a community-based educational program focusing on early detection and treatment.
This award also helps to facilitate partnerships between CCRTD and other research centers, such as the Integrative Cancer Research Center at the Georgia Institute of Technology in Atlanta and the Winship Cancer Institute at Emory University in Atlanta. These three centers partnered in forming the Collaborative Center for Cancer Genomics. Investigators from each of these centers perform DNA sequencing of individual tumors to identify novel genetic variations contributing to differences in prostate cancer susceptibility, progression and response to therapy in black men.
“This award will help to build the most comprehensive prostate cancer research and educational program in the country, and help to sustain vital partnerships required to address this disease and its disproportionate impact on [black] men,” said Dr. Shafiq A. Khan, principal investigator and director, CCRTD, and Georgia Research Alliance Eminent Scholar.
High Fruit and Veg Consumption May Reduce Breast Cancer RiskNews
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.READ MORE
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Why Might Super-Tasters be at Higher Cancer Risk?News
High bitter-taste sensitivity is associated with a significantly increased risk of cancer in older British women, according to researchers who conducted a unique study of 5,500 women whose diet, lifestyle and health has been tracked for about 20 years.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018